Pesquisas alternativas:
does develop » boys develop (Expandir a Pesquisa), loss develop (Expandir a Pesquisa), does developing (Expandir a Pesquisa)
develop them » develop type (Expandir a Pesquisa), develop age (Expandir a Pesquisa)
level rather » levels rather (Expandir a Pesquisa), level rate (Expandir a Pesquisa), level race (Expandir a Pesquisa)
live rather » naive rather (Expandir a Pesquisa), live farther (Expandir a Pesquisa), size rather (Expandir a Pesquisa)
drugs does » drugs do (Expandir a Pesquisa)
dose level » dose levels (Expandir a Pesquisa), noise level (Expandir a Pesquisa), dose live (Expandir a Pesquisa)
drug does » drug doses (Expandir a Pesquisa), drug de (Expandir a Pesquisa), drug diet (Expandir a Pesquisa)
does live » does liver (Expandir a Pesquisa), does olive (Expandir a Pesquisa), does life (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
does develop » boys develop (Expandir a Pesquisa), loss develop (Expandir a Pesquisa), does developing (Expandir a Pesquisa)
develop them » develop type (Expandir a Pesquisa), develop age (Expandir a Pesquisa)
level rather » levels rather (Expandir a Pesquisa), level rate (Expandir a Pesquisa), level race (Expandir a Pesquisa)
live rather » naive rather (Expandir a Pesquisa), live farther (Expandir a Pesquisa), size rather (Expandir a Pesquisa)
drugs does » drugs do (Expandir a Pesquisa)
dose level » dose levels (Expandir a Pesquisa), noise level (Expandir a Pesquisa), dose live (Expandir a Pesquisa)
drug does » drug doses (Expandir a Pesquisa), drug de (Expandir a Pesquisa), drug diet (Expandir a Pesquisa)
does live » does liver (Expandir a Pesquisa), does olive (Expandir a Pesquisa), does life (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
1
Por Halicki, Priscila C. B., Ferreira, Laís A., De Moura, Kelly C. G., Carneiro, Paula F., Del Rio, Karina P., Carvalho, Tatiane dos S. C., Pinto, Maria do C. F. R., da Silva, Pedro E. A., Ramos, Daniela F.
Publicado no Front Microbiol (2018)
“... of resistant Mycobacterium tuberculosis strains. These barriers reinforcing the need for development of new...”Publicado no Front Microbiol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Csete, Joanne, Kamarulzaman, Adeeba, Kazatchkine, Michel, Altice, Frederick, Balicki, Marek, Buxton, Julia, Cepeda, Javier, Comfort, Megan, Goosby, Eric, Goulão, João, Hart, Carl, Horton, Richard, Kerr, Thomas, Lajous, Alejandro Madrazo, Lewis, Stephen, Martin, Natasha, Mejía, Daniel, Mathiesson, David, Obot, Isidore, Ogunrombi, Adeolu, Sherman, Susan, Stone, Jack, Vallath, Nandini, Vickerman, Peter, Zábranský, Tomáš, Beyrer, Chris
Publicado no Lancet (2016)
“... their health, human rights, and development impact. The Johns Hopkins – Lancet Commission on Drug Policy...”Publicado no Lancet (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Hendrikx, Jeroen J.M.A., Haanen, John B.A.G., Voest, Emile E., Schellens, Jan H.M., Huitema, Alwin D.R., Beijnen, Jos H.
Publicado no Oncologist (2017)
Assuntos:
“...New Drug Development and Clinical Pharmacology...”Publicado no Oncologist (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Zhang, Meijuan, Wang, Haiying, Zhao, Jinbing, Chen, Cong, Leak, Rehana K., Xu, Yun, Vosler, Peter, Gao, Yanqin, Zhang, Feng
Publicado em 2013
“... to induce therapeutic hypothermia have been established; however, most of them are not clinically feasible...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Artigo
5
“...Informal health providers ranging from drug vendors to traditional healers account for a large...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
“... them into drug-design and -discovery workflows while trying to answer a critical question: are QM-based...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Wesnes, Keith A.
Publicado em 2000
“...This paper reviews the value and utility of measuring cognitive function in the development of new...”Publicado em 2000
Obter o texto integral
Obter o texto integral
Artigo
8
“... could be based on an "all or none" detection of the marker rather than on drug levels....”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
10
Por Yadav, Bhagwan, Wennerberg, Krister, Aittokallio, Tero, Tang, Jing
Publicado no Comput Struct Biotechnol J (2015)
“... positive rate at a low level. Further, rather than relying on a single parameter to assess drug interaction...”Publicado no Comput Struct Biotechnol J (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por A. E. Karateyev
Publicado em 2013-12-01
Assuntos:
“...nonsteroidal anti-inflammatory drugs...”Publicado em 2013-12-01
Obter o texto integral
Artigo
12
13
“... approach “Design of Experiments (DoE)” as applicable to formulation development of microparticles...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Takenaka, Yukinori, Fukumori, Tomoharu, Yoshii, Tadashi, Oka, Natsuo, Inohara, Hidenori, Kim, Hyeong-Reh Choi, Bresalier, Robert S., Raz, Avraham
Publicado em 2004
Assuntos:
“...Cell Growth and Development...”Publicado em 2004
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Pomel, Sébastien, Mao, Wei, Ha-Duong, Tâp, Cavé, Christian, Loiseau, Philippe M.
Publicado no Front Cell Infect Microbiol (2019)
“... countries around the world. In order to find new antileishmanial drugs, an original approach consists...”Publicado no Front Cell Infect Microbiol (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Yildirim, Oktay, Gottwald, Matthias, Schüler, Peter, Michel, Martin C.
Publicado no Front Pharmacol (2016)
“...Drug development faces the double challenge of increasing costs and increasing pressure on pricing...”Publicado no Front Pharmacol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Supp, Gernot G., Higgen, Focko L., Hipp, Joerg F., Engel, Andreas K., Siegel, Markus
Publicado no Front Pharmacol (2018)
“... AEPs during remifentanil medication. This decrease was predicted by drug dose, rather than sedation...”Publicado no Front Pharmacol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Mingote, Susana, Masson, Justine, Gellman, Celia, Thomsen, Gretchen M., Lin, Chyuan-Sheng, Merker, Robert J., Gaisler-Salomon, Inna, Wang, Yvonne, Ernst, Rachel, Hen, René, Rayport, Stephen
Publicado no Front Syst Neurosci (2016)
“...Genetic pharmacotherapy is an early drug development strategy for the identification of novel CNS...”Publicado no Front Syst Neurosci (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
“... are continuously being made across areas, but how does one optimally combine and focus them to maximize...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Song, Chull S., Moses, Harold L., Rosenthal, Alan S., Gelb, Nancy A., Kappas, Attallah
Publicado em 1971
“... inducers of hepatic ALAS does, however, develop in neonatal animals so that by approximately 5–6 wk of age...”Publicado em 1971
Obter o texto integral
Obter o texto integral
Artigo